Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology EquipmentEnzyme

PUBLISHER: Grand View Research | PRODUCT CODE: 1587551

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1587551

Diagnostic Enzymes Market Size, Share & Trends Analysis Report By Type (Taq Polymerase, MMLV RT, HIV RT), By Application (Diabetes, Oncology, Cardiology), By Product, By End-use, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Diagnostic Enzymes Market Growth & Trends:

The global diagnostic enzymes market size is expected to reach USD 7.71 billion by 2030, registering a CAGR of 7.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growth of the diagnostic enzymes market is attributed to rising demand for the enzymes in diagnostics with wide applications in pathology. Moreover, advancements in diagnostic techniques for viral infection are anticipated to propel the market growth.

Diagnostic enzymes are widely adopted owing to the higher sensitivity and accuracy offered by enzyme activity. The enzyme activities can be earlier than clinical signs and other diagnostic indicators. Biosensors are becoming a popular potential tool for medical diagnostics, pathogen detection, and monitoring. Biosensors have gained popularity owing to the accuracy, sensitivity, selectivity, and rapid detection strategies that can be used routinely. Diagnosis of serum levels of the enzymes has been used as an indicator of the cellular damage that results in the release of the intercellular components into the bloodstream.

Viral infections of the respiratory tract are among the most common disorders in humans, and the ones caused due to the outbreak of emerging viruses, such as COVID-19, have posed a threat to public health. Therefore, detection of the viral pathogens is vital to stop the occurrence of such epidemics and prevent the unnecessary use of antibiotics. Therefore, novel diagnostic strategies have been adopted by the key players. LightMix (Roche Molecular Diagnostics, Switzerland), AccuPower (Bioneer, Korea), PowerChek (Kogene Biotech, Korea), Anyplex (Seegene, Korea), UltraFast kits (Nanobiosys, Korea), and DiaPlexQ (SolGent, Korea) are some of the commercially available RT-PCR kits for MERS-CoV RNA detection with sensitivities as high as 99.03%.

An increase in the number of diagnostic enzyme tests has led to a boost in recommendations and guidelines with a number of publications on their performance. Moreover, reimbursement pathways lack clear guidelines and systematic Health Technology Assessment (HTA). Various factors influencing payer decisions for diagnostic enzyme tests include FDA clearance, physician support & clinical guidelines, competitor coverage policies, cost/benefit analyses, results of HTAs, and employer or advocacy group demands.

Furthermore, key players operating in the market are focusing on expanding and launching products that can be used for a wide range of applications. For instance, in March 2022, Meridian Bioscience, Inc. launched two master mixes, which can be used in non-invasive liquid biopsy. The launch of such breakthrough technologies enables better analysis of the performance levels as compared to traditional qPCR from the purified nucleic acid.

Diagnostic Enzymes Market Report Highlights:

  • The glucose oxidase/dehydrogenase segment accounted for the largest revenue share of 9.3% in 2024. Glucose oxidase (GOx) is in high demand primarily due to its essential role in glucose monitoring and its increasing applications in various biomedical fields.
  • The lactate dehydrogenase (LDH) segment is anticipated to experience substantial growth throughout the forecast period, largely driven by the rising adoption of molecular devices for diabetes management.
  • The infectious diseases segment held the largest market share of 36.0% in 2024. The widespread application of PCR technology has significantly advanced the early identification and treatment of infectious diseases.
  • The oncology segment is expected to grow at a CAGR of 8.8% over the forecast period.
  • The clinical enzyme segment accounted for the largest revenue share of 65.3% in 2024, largely due to the increasing application of enzymes in clinical chemistry.
  • The clinical laboratories segment held the largest market share of 48.2% in 2024. The segment growth is driven by multiple factors.
Show more
Product Code: GVR-4-68040-003-4

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. Application
    • 1.2.4. End Use
    • 1.2.5. Regional Scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Diagnostic Enzymes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rise in the demand for enzymes in pathology
      • 3.2.1.2. Advancements in diagnostic testing of viral infection
      • 3.2.1.3. Increase in the demand for Point-of-Care testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of enzyme-based diagnostic tests
      • 3.2.2.2. Regulatory & reimbursement hurdles for enzyme diagnostics
  • 3.3. Diagnostic Enzymes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Diagnostic Enzymes Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Diagnostic Enzymes Market: Type Movement Analysis
  • 4.3. Diagnostic Enzymes Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Taq Polymerase
    • 4.5.1. Taq Polymerase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. MMLV RT
    • 4.6.1. MMLV RT Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. HIV RT
    • 4.7.1. HIV RT Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Hot Start Taq Pol
    • 4.8.1. Hot Start Taq Pol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. UNG
    • 4.9.1. UNG Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Rnase Inhibitors
    • 4.10.1. Rnase Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.11. Bst Polymerase (LAMP ENZYME)
    • 4.11.1. Bst Polymerase (LAMP ENZYME) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.12. PCR Master Mix
    • 4.12.1. PCR Master Mix Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.13. Lyophilized Polymerase
    • 4.13.1. Lyophilized Polymerase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.14. T7 Rna Polymerase
    • 4.14.1. T7 Rna Polymerase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.15. Cas9 Enzyme
    • 4.15.1. Cas9 Enzyme Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.16. Acid Phosphatase
    • 4.16.1. Acid Phosphatase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.17. Alanine Aminotransferase
    • 4.17.1. Alanine Aminotransferase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.18. Alkaline Phosphatase
    • 4.18.1. Alkaline Phosphatase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.19. Amylase
    • 4.19.1. Amylase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.20. Angiotensin Converting Enzyme
    • 4.20.1. Angiotensin Converting Enzyme Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.21. Aspartate Aminotransferase
    • 4.21.1. Aspartate Aminotransferase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.22. Cholinesterase
    • 4.22.1. Cholinesterase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.23. Creatinine Kinase
    • 4.23.1. Creatinine Kinase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.24. Gamma Glutamyl Transferase
    • 4.24.1. Gamma Glutamyl Transferase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.25. Lactate Dehydrogenase
    • 4.25.1. Lactate Dehydrogenase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.26. Renin
    • 4.26.1. Renin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.27. Glucose Oxidase/Glucose Dehydrogenase
    • 4.27.1. Glucose Oxidase/Glucose Dehydrogenase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.28. Urease
    • 4.28.1. Urease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.29. Lactate Oxidase
    • 4.29.1. Lactate Oxidase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.30. Horseradish Peroxide
    • 4.30.1. Horseradish Peroxide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.31. Glutamate Oxidase
    • 4.31.1. Glutamate Oxidase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.32. Others
    • 4.32.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Diagnostic Enzymes Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Diagnostic Enzymes Market: Application Movement Analysis
  • 5.3. Diagnostic Enzymes Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Diabetes
    • 5.5.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Cardiology
    • 5.7.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Infectious Disease
    • 5.8.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Nephrology
    • 5.9.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Autoimmune Diseases
    • 5.10.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Diagnostic Enzymes Market: Product Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Diagnostic Enzymes Market: Product Movement Analysis
  • 6.3. Diagnostic Enzymes Market by Product Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Molecular Enzymes
    • 6.5.1. Molecular Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Clinical Enzymes
    • 6.6.1. Clinical Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Diagnostic Enzymes Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Diagnostic Enzymes Market: End Use Movement Analysis
  • 7.3. Diagnostic Enzymes Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Hospital
    • 7.5.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Clinical Laboratories
    • 7.6.1. Clinical Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Diagnostic Enzymes Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Recent Developments & Impact Analysis by Key Market Participants
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. Key Company Profiles
    • 9.4.1. Takara Bio, Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Promega Corporation
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Enzo Biochem Inc
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Merck KGaA
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Thermo Fisher Scientific, Inc
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Creative Enzymes
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. F. Hoffmann-La Roche Ltd.
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Solis BioDyne
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Ambliqon A/S.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Yashraj Biotechnology Ltd.
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-003-4

List of Tables

  • Table 1. List of abbreviation
  • Table 2. North America Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 3. North America Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 4. North America Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 5. North America Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 6. North America Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 7. U.S. Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 8. U.S. Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 9. U.S. Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 10. U.S. Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 11. Canada Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 12. Canada Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 13. Canada Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 14. Canada Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 15. Mexico Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 16. Mexico Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 17. Mexico Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 18. Mexico Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 19. Europe Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 20. Europe Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 21. Europe Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 22. Europe Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 23. Europe Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 24. Germany Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 25. Germany Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 26. Germany Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 27. Germany Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 28. UK Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 29. UK Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 30. UK Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 31. UK Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 32. France Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 33. France Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 34. France Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 35. France Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 36. Italy Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 37. Italy Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 38. Italy Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 39. Italy Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 40. Spain Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 41. Spain Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 42. Spain Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 43. Spain Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Denmark Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 45. Denmark Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 46. Denmark Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 47. Denmark Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 48. Sweden Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 49. Sweden Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 50. Sweden Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 51. Sweden Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 52. Norway Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 53. Norway Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 54. Norway Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 55. Norway Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 56. Asia Pacific Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 57. Asia Pacific Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 58. Asia Pacific Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 59. Asia Pacific Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 60. Asia Pacific Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 61. China Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 62. China Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 63. China Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 64. China Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 65. Japan Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 66. Japan Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 67. Japan Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 68. Japan Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 69. India Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 70. India Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 71. India Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 72. India Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 73. South Korea Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 74. South Korea Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 75. South Korea Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 76. South Korea Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 77. Australia Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 78. Australia Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 79. Australia Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 80. Australia Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 81. Thailand Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 82. Thailand Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 83. Thailand Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 84. Thailand Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 85. Latin America Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 86. Latin America Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 87. Latin America Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 88. Latin America Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 89. Latin America Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 90. Brazil Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 91. Brazil Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 92. Brazil Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 93. Brazil Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 94. Argentina Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 95. Argentina Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 96. Argentina Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 97. Argentina Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 98. MEA Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 99. MEA Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 100. MEA Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 101. MEA Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 102. MEA Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 103. South Africa Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 104. South Africa Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 105. South Africa Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 106. South Africa Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 107. Saudi Arabia Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 108. Saudi Arabia Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 109. Saudi Arabia Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 110. Saudi Arabia Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 111. UAE Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 112. UAE Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 113. UAE Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 114. UAE Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 115. Kuwait Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 116. Kuwait Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 117. Kuwait Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 118. Kuwait Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1. Market research process
  • Fig. 2. Data triangulation techniques
  • Fig. 3. Primary research pattern
  • Fig. 4. Primary interviews in North America
  • Fig. 5. Primary interviews in Europe
  • Fig. 6. Primary interviews in APAC
  • Fig. 7. Primary interviews in Latin America
  • Fig. 8. Primary interviews in MEA
  • Fig. 9. Market research approaches
  • Fig. 10. Value-chain-based sizing & forecasting
  • Fig. 11. QFD modeling for market share assessment
  • Fig. 12. Market formulation & validation
  • Fig. 13. Diagnostic Enzymes market: market outlook
  • Fig. 14. Diagnostic Enzymes competitive insights
  • Fig. 15. Parent market outlook
  • Fig. 16. Related/ancillary market outlook
  • Fig. 17. Diagnostic Enzymes market driver impact
  • Fig. 18. Diagnostic Enzymes market restraint impact
  • Fig. 19. Diagnostic Enzymes market: Type movement analysis
  • Fig. 20. Diagnostic Enzymes market: Type outlook and key takeaways
  • Fig. 21. Taq polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22. MMLV-RT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23. HIV RT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24. Hot start Taq pol market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25. UNG market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26. RNase inhibitor market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27. Bst polymerase (LAMP enzyme) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28. PCR Master Mix market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29. Lyophilised Polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30. T7 RNA polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31. Cas9 enzyme market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32. Acid phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33. Alanine aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34. Alkaline phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35. Amylase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36. Angiotensin converting enzyme market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37. Aspartate aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38. Cholinesterase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39. Creatinine kinase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40. Gamma glutamyl transferase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41. Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42. Renin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43. Glucose oxidase/glucose dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44. Urease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45. Lactate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46. Horseradish peroxidase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47. Glutamate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48. Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49. Diagnostic Enzymes market: Application movement analysis
  • Fig. 50. Diagnostic Enzymes market: Application outlook and key takeaways
  • Fig. 51. Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52. Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53. Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54. Infectious Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55. Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56. Autoimmune Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57. Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58. Diagnostic Enzymes market: Product movement analysis
  • Fig. 59. Diagnostic Enzymes market: Product outlook and key takeaways
  • Fig. 60. Molecular Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61. Clinical Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62. Diagnostic Enzymes market: End Use movement analysis
  • Fig. 63. Diagnostic Enzymes market: End Use outlook and key takeaways
  • Fig. 64. Hospital market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65. Clinical Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66. Other End Users market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67. Global Diagnostic Enzymes market: Regional movement analysis
  • Fig. 68. Global Diagnostic Enzymes market: Regional outlook and key takeaways
  • Fig. 69. Global Diagnostic Enzymes market share and leading players
  • Fig. 70. North America, by country
  • Fig. 71. North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72. U.S. key country dynamics
  • Fig. 73. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74. Canada key country dynamics
  • Fig. 75. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76. Mexico key country dynamics
  • Fig. 77. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79. UK key country dynamics
  • Fig. 80. UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81. Germany key country dynamics
  • Fig. 82. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83. France key country dynamics
  • Fig. 84. France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85. Italy key country dynamics
  • Fig. 86. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87. Spain key country dynamics
  • Fig. 88. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89. Denmark key country dynamics
  • Fig. 90. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91. Sweden key country dynamics
  • Fig. 92. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93. Norway key country dynamics
  • Fig. 94. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96. China key country dynamics
  • Fig. 97. China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98. Japan key country dynamics
  • Fig. 99. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100. India key country dynamics
  • Fig. 101. India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102. Thailand key country dynamics
  • Fig. 103. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104. South Korea key country dynamics
  • Fig. 105. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106. Australia key country dynamics
  • Fig. 107. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109. Brazil key country dynamics
  • Fig. 110. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111. Argentina key country dynamics
  • Fig. 112. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 113. Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 114. South Africa key country dynamics
  • Fig. 115. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 116. Saudi Arabia key country dynamics
  • Fig. 117. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 118. UAE key country dynamics
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!